🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
BridgeBio Oncology Therapeutics, Inc. (BBOT)
NASDAQ: BBOT · Real-Time Price · USD
1.810
-0.050 (-2.69%)
At close: Nov 20, 2026, 4:00 PM EST
1.840
+0.030 (1.66%)
After-hours: Nov 20, 2026, 5:33 PM EST

BBOT Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23
Net Income
-171.53-134.04-74.28-64.7
Depreciation & Amortization
0.760.610.210.09
Loss (Gain) From Sale of Investments
0.37-1.26-1.54-
Stock-Based Compensation
18.795.874.4316.47
Other Operating Activities
0.018.490.56-
Change in Accounts Payable
6.47-1.842.50.27
Change in Other Net Operating Assets
-5.748.2713.1-4.2
Operating Cash Flow
-150.88-113.89-55.03-52.08
Operating Cash Flow Growth
----

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23
Capital Expenditures
-0.16-0.61-0.05-0.41
Investment in Securities
-181.4273.93-122.89-
Other Investing Activities
--2.41-2.41
Investing Cash Flow
-181.5773.33-120.53-2.82

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23
Issuance of Common Stock
0.98373.51.113.62
Other Financing Activities
-0.79-12.32--
Financing Cash Flow
0.19383.4206.2955.12

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23
Net Cash Flow
-332.26342.8430.730.23

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23
Free Cash Flow
-151.03-114.5-55.08-52.49
Free Cash Flow Growth
----
Free Cash Flow Per Share
-1.88-3.68-4268.47-420.87
Levered Free Cash Flow
-89.13-74.19-42.53-
Unlevered Free Cash Flow
-89.13-74.19-42.53-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23
Change in Working Capital
0.736.4315.59-3.94